Rezoluteincis A Biopharmaceutical Company Based In Redwood Citycaliforniathat Specializes In Rare Metabolic Diseasesfounded In 2010 And Rebranded In 2017The Company Is Dedicated To Developing Therapies For Conditions With Significant Unmet Medical Needsparticularly In Pediatric And Metabolic Disorders The Company S Pipeline Includes Ersodetugrz358 Currently In Phase 3 Clinical Trials For Congenital Hyperinsulinismand Rz402In Phase 2 Trials For Diabetic Macular Edemaboth Products Aim To Address Critical Health Challenges Faced By Patientsincluding Life Threatening Hypoglycemia In Children And Vision Loss In Diabetic Patientsrezolute S Leadershipunder Ceo Nevan Elambrings Extensive Experience In Healthcare And Technologyguiding The Companyae S Focus On Innovative Treatments For Rare Diseases
| Company Name | Rezolute Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
